Prosecution Insights
Last updated: April 19, 2026

Ixaka France

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17925892 Promoter Sequences for In Vitro and In Vivo Expression of Gene Therapy Products in CD3+ Cells ARIETI, RUTH SOPHIA 1635 Non-Final OA Nov 17, 2022
17777106 Polymer-Encapsulated Viral Vectors for In Vivo Genetic Therapy MATALKAH, FATIMAH KHALAF 1638 Final Rejection May 16, 2022

Managing Ixaka France's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month